Brachy beat down.

Yet another retrospective analysis reports better outcomes with brachytherapy than with external beam radiation (EBRT) alone for prostate cancer, except this time it’s looking at intermediate risk disease. This look at cases treated at Kaiser Permanente demonstrate significantly less biochemical failures at 10 years following brachy than either EBRT or surgery, maintained on multivariate analysis with propensity score matching. | Goy, Urology 2019